. . . . . . . . . . . . . . "p(HGNC:NF1) -| p(HGNC:CDKN2A)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Importantly, GRD expression resulted in the activation of both the Rb and p53 pathways (Figure 3D), and the same cell cycle inhibitors were upregulated in human cells treated with NF1- specific shRNA constructs (Figure 3F), with the exception of p16, which was only activated in NF1KD- and not GRD-expressing cells." . . "Selventa" . . . . "2014-07-03T14:33:07.506+02:00"^^ . . .